Cargando…

Early stage primary ovarian mucinous carcinoma: Outcome-based clinicopathological study in comparison with serous carcinoma

OBJECTIVE: To compare clinicopathological characteristics and survival rates between patients with primary ovarian mucinous carcinoma and those with primary ovarian serous carcinoma. METHODS: This retrospective study reviewed archival tumour specimens, originally diagnosed as primary ovarian mucinou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Qifang, Lu, Bingjian, Ye, Jing, Lu, Weiguo, Xie, Xing, Wang, Xinyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Clinical Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580051/ https://www.ncbi.nlm.nih.gov/pubmed/26880793 http://dx.doi.org/10.1177/0300060515597930

Ejemplares similares

The expressions of bHLH gene HES1 and HES5 in advanced ovarian serous adenocarcinomas and their prognostic significance: a retrospective clinical study
por: Wang, Xinyu, et al.
Publicado: (2009)

Poorly differentiated mucinous carcinoma with signet ring cells in an ovarian endometriotic cyst: a case report
por: Jiao, Yurong, et al.
Publicado: (2019)

Clinicopathological and genomic features of breast mucinous carcinoma
por: Lu, Kebin, et al.
Publicado: (2020)

Mucinous Breast Carcinoma: Clinicopathological Comparison With Invasive Ductal Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2021)

Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma
por: Hollis, Robert L., et al.
Publicado: (2021)

MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples
por: Li, Xiao, et al.
Publicado: (2013)

Comparison of stage III mucinous and serous ovarian cancer: a case-control study
por: Firat Cuylan, Zeliha, et al.
Publicado: (2018)

Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis
por: Hada, Taira, et al.
Publicado: (2022)

Mucinous Carcinoma of the Breast in Comparison with Invasive Ductal Carcinoma: Clinicopathologic Characteristics and Prognosis
por: Bae, Soo Youn, et al.
Publicado: (2011)

Clinicopathological and biological significance of aberrant activation of glycogen synthase kinase-3 in ovarian cancer
por: Fu, Yunfeng, et al.
Publicado: (2014)

Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas.
por: Tapper, J., et al.
Publicado: (1997)

Hypermethylated APC in serous carcinoma based on a meta-analysis of ovarian cancer
por: Shen, Chunyan, et al.
Publicado: (2016)

Surgical staging of apparent early-stage ovarian mucinous carcinoma
por: Yuan, Zhen, et al.
Publicado: (2022)

Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours
por: Wang, Fujun, et al.
Publicado: (2023)

Characterization of Primary Mucinous Ovarian Cancer by Diffusion-Weighted and Dynamic Contrast Enhancement MRI in Comparison with Serous Ovarian Cancer
por: Grabowska-Derlatka, Laretta, et al.
Publicado: (2023)

A novel algorithm for better distinction of primary mucinous ovarian carcinomas and mucinous carcinomas metastatic to the ovary
por: Simons, Michiel, et al.
Publicado: (2019)

Clinicopathological Characteristics of Mucinous Carcinoma of the Breast in Korea: Comparison with Invasive Ductal Carcinoma-Not Otherwise Specified
por: Park, Seho, et al.
Publicado: (2010)

Paclitaxel plus Carboplatin Chemotherapy for Primary Peritoneal Carcinoma: A Study of 22 Cases and Comparison with Stage III–IV Ovarian Serous Carcinoma
por: Kawaguchi, R., et al.
Publicado: (2012)

EGFR Immunoexpression in Malignant Serous and Mucinous Ovarian Tumors
por: CÎRSTEA, A.E., et al.
Publicado: (2018)

Serous carcinoma of the uterine cervix: Clinicopathological features differing from serous carcinomas of other female organs
por: Kitade, Shoko, et al.
Publicado: (2019)

Prognosis in primary mucinous ovarian carcinoma: focusing on the five pathological findings indicating metastatic mucinous carcinoma to the ovary
por: Lee, Sang won, et al.
Publicado: (2021)

Clinicopathologic and survival results in serous endometrium carcinoma and subgroup analysis for mixed serous and pure serous histology
por: Kaban, Alpaslan, et al.
Publicado: (2018)

Correlation of FOXC1 protein with clinicopathological features in serous ovarian tumors
por: WANG, LU-YING, et al.
Publicado: (2016)

The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma
por: Cheng, Zhao, et al.
Publicado: (2022)

Differences between primary peritoneal serous carcinoma and advanced serous ovarian carcinoma: a study based on the SEER database
por: Li, Xiaoduo, et al.
Publicado: (2021)

Ovarian mucinous tumors with mural nodules: immunohistochemical and molecular analysis of 3 cases
por: Shao, Ying, et al.
Publicado: (2020)

Clinicopathological practice in the differential diagnosis of mucoepidermoid carcinoma from neoplasms with mucinous component
por: Zhu, Yuelu, et al.
Publicado: (2023)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Mucins and mucinous ovarian carcinoma: Development, differential diagnosis, and treatment
por: Wang, Yicong, et al.
Publicado: (2023)

Recent Insights into Mucinous Ovarian Carcinoma
por: Ricci, Francesca, et al.
Publicado: (2018)

Therapeutic options for mucinous ovarian carcinoma☆
por: Gorringe, Kylie L., et al.
Publicado: (2020)

High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the “SET” feature of high-grade serous carcinoma to the “STEM” feature
por: Hatano, Yuichiro, et al.
Publicado: (2019)

Development of survival predictors for high-grade serous ovarian cancer based on stable radiomic features from computed tomography images
por: Hu, Jiaqi, et al.
Publicado: (2022)

Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea
por: Kim, Se Ik, et al.
Publicado: (2022)

Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
por: Österberg, Lovisa, et al.
Publicado: (2009)

Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients
por: Engelstaedter, Verena, et al.
Publicado: (2012)

Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases
por: Lu, Bingjian, et al.
Publicado: (2016)

Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas
por: Cheon, Dong‐Joo, et al.
Publicado: (2014)

The molecular origin and taxonomy of mucinous ovarian carcinoma
por: Cheasley, Dane, et al.
Publicado: (2019)

Genomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical Practice
por: Dong, Anliang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1o1h94fu8952rork88clfdj93c